AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02271191 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicardipine
Description: nicardipine 1-5 ug/kg/min and remifentanil 0.05 ug/kg/min during deliberate hypotension in spine surgery
Study NCT02271191 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nicardipine
Description: nicardipine 1-5 ug/kg/min and remifentanil 0.05 ug/kg/min during deliberate hypotension in spine surgery
Study NCT00667849 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: sham device identical to active device with the exception of administration of ultrasound
Study NCT00995423 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CoroflexTM Please
Description: highly flexible CoroflexTM Please-Stent
Study NCT00995423 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel-eluting stent
Description: Paclitaxel-eluting stent
Study NCT02366156 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Three placebo capsules consumed prior to breakfast each day for 4 weeks
Study NCT02366156 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Low Dose Grape Blend
Description: Three low dose grape blend capsules consumed prior to breakfast each day for 4 weeks.
Study NCT02366156 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: High Dose Grape Blend
Description: Three high dose grape blend capsules consumed prior to breakfast each day for 4 weeks.
Study NCT05155774 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Twin block
Description: Twin Block orthodontic appliance for treating patients with Angle class II molar relationship and a large horizontal overjet, often in combination with an incomplete lip closure
Study NCT05155774 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Twin block
Description: Twin Block orthodontic appliance for treating patients with Angle class II molar relationship and a large horizontal overjet, often in combination with an incomplete lip closure
Study NCT03458156 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SLE group
Description: The patients will be assigned to systemic lupus erythematosus (SLE) group, receiving umbilical cord mesenchymal stem cell transplantation.
Study NCT03458156 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LN group
Description: The patients will be assigned to lupus nephritis (LN) group, receiving umbilical cord mesenchymal stem cell transplantation.
Study NCT03458156 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: the control group
Description: The patients will be assigned to the control group.
Study NCT03356249 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Next-Generation Sequencing
Description: In 500 patients with suspected or proven sepsis or septic shock (according to the Sepsis-3 definitions), patients´ characteristics and routine blood parameters will be determined at sepsis onset as well as 72 hours afterwards. At the same time points, 2 sets of blood cultures and one blood tube for Next-Generation Sequencing (NGS)-diagnostics will be collected. An evaluation of outcome will be performed at 28 days after sepsis onset.
Study NCT04990960 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: During each session (45 minutes)the patient was assessed and trained in self-treatment exercises assigned to treat their cords. This later method was chosen to ensure regular participation in their exercises and early correction of any inaccuracies in the implementation of the exercises regarding AWS treatment . Or the Physiotherapist worked actively on cords with soft or vigorous stretching.
Study NCT04990960 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: During each session (45 minutes)the patient was assessed and trained in self-treatment exercises assigned to treat their cords. This later method was chosen to ensure regular participation in their exercises and early correction of any inaccuracies in the implementation of the exercises regarding AWS treatment . Or the Physiotherapist worked actively on cords with soft or vigorous stretching.
Study NCT03042052 — intervention group
Intervention type: DRUG
Intervention: detrusor infection of Botulinum toxin
Description: detrusor injection
Study NCT04059120 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group whit specific stretching
Description: The intervention involves a reality of physical, physical, different exercise, similar to the realist of high-performance athletes. However, this is the physical load, which is reduced with specific exercises of stretching and with it the factors that determine the syndrome of overtraining
Study NCT04059120 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group whit out specific stretching
Description: The intervention involves a reality of physical, physical, different exercise, similar to the realist of high-performance athletes. However, this is the physical load, which is reduced less than specific exercises of stretching and with it the factors that determine the syndrome of overtraining
Study NCT02020317 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: decision support in potassium-inc. drug-drug-interactions
Description: display of computer-based reminders for serum potassium monitoring and hyperkalemia alerts
Study NCT03372174 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Maintaining mechanical ventilation during surgery
Description: dead space ventilation using tidal volume of 2.5 mL/kg/pbw (predicted body weight) with 5-7 cm H2O Positive end-expiratory pressure
Study NCT00587756 — intervention group
Intervention type: PROCEDURE
Intervention: One-stage ultrasound guided hepatectomy
Description: Surgical strategy was based on tumor-vessel relationship at intraoperative ultrasonography (IOUS)and on findings at color-Doppler IOUS.
Study NCT03372174 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Absence of mechanical ventilation during surgery
Description: absence of mechanical ventilation (and no Positive end-expiratory pressure) by disconnecting the tracheal tube from the ventilator
Study NCT02211430 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Counseling (CBC)
Description: Participants of CBC were educated about the effects of smoking on their personal health and their pregnancy during session 1 (45 minutes counseling), and were encouraged to explore their risk perceptions and emotions, for themselves and their unborn child. During session 2, the 15-minute counseling segment highlighted the cognitive and emotion barriers undermining the participant's motivation to quit and the self-regulatory techniques for resisting personal smoking triggers. Session 3 (45 minutes counseling) involved reviewing smoking status and smoking history over the course of the pregnancy, as well as the effects of smoking on both their health and the health of their infant. Booster session was held by phone for 15 min.
Study NCT02211430 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice (BC) Control
Description: For ethical considerations, and consistent with practice guidelines for treating tobacco addiction (Fiore et al., 2000) which mandates that every pregnant smoker be offered smoking cessation treatment, the control group has been designed to be comparable to the current best practice guidelines for smoking cessation treatments. This condition, devised from a review of the current literature, will include one brief (5-15 minutes) prenatal individual session (session 1) consisting of smoking cessation education and advice, on-site brochure pick up (session 2), and a second brief postpartum individual session (session 3) followed by receipt of a newsletter (session 4).
Study NCT01730586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abraxane
Description: 220 mg/m2 administered by vein on Day 1. A cycle of therapy is defined as 21 days.
Study NCT02714283 — intervention group
Intervention type: DRUG
Intervention: inhaled corticosteroid therapy
Description: We will evaluate and compare the clinical effectiveness and safety of long-term inhaled corticosteroid and macrolide antimicrobial therapies
Study NCT02714283 — intervention group
Intervention type: DRUG
Intervention: macrolide therapy
Description: We will evaluate and compare the clinical effectiveness and safety of long-term inhaled corticosteroid and macrolide antimicrobial therapies
Study NCT00061633 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telavancin
Description: Telavancin 7.5 mg/kg/day IV (intravenously) for up to 14 days
Study NCT00061633 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vancomycin or antistaphylococcal penicillin
Description: Vancomycin 1 Gram IV (intravenously) every 12 hrs or nafcillin 2 Grams, oxacillin 2 Grams, or (in South Africa) cloxacillin 0.5 - 1 Gram, IV (intravenously) every 6 hrs for up to 14 days.
Study NCT01979458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PSE
Study NCT02725541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab emtansine
Description: HER2-targeted antibody drug conjugate of trastuzumab and DM1
Study NCT02400541 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy
Description: Our scheme comprises 10 biweekly sessions ( 5 in group and 5 single) . Each session last about 45 minutes.~Individual sessions will be held with the patient and a therapist trained in the CRT; group sessions will be led by two therapists trained in CRT and regroup the maximum 5 patients.
Study NCT02400541 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: relaxation therapy
Description: Our scheme comprises 10 biweekly sessions. Each session last about 45 minutes.
Study NCT02387554 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HGP0904
Study NCT02387554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HGP0904
Study NCT02387554 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HGP0608
Study NCT02387554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HGP0608
Study NCT02387554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HGP1405
Study NCT02387554 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HGP1405
Study NCT04487652 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gingival recession coverage
Description: The Modified Coronally Advanced Tunnel technique in conjunction with a palatal subepithelial connective tissue graft will be performed.
Study NCT01107509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: everolimus
Description: 10 mg/ day everolimus in the form of an oral tablet for 12 weeks leading up to nephrectomy (with a 1-week perioperative washout period) in patients with locally advanced disease and re-initiating the drug postoperatively in patients with metastatic disease for up to 24 months, or until disease progression. Dosage may be reduced at any point to 5 mg/ day in the event of any grade 3/ 4 toxicity.
Study NCT04487652 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Gingival recession coverage
Description: The Modified Coronally Advanced Tunnel technique in conjunction with a palatal subepithelial connective tissue graft will be performed.
Study NCT04487652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: with CoQ10 spray application
Description: After surgical recession coverage a CoQ10 spray will be applied during the early phase of wound healing.
Study NCT04487652 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: with placebo spray application
Description: After surgical recession coverage a placebo spray will be applied during the early phase of wound healing.
Study NCT00988572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation
Description: The intervention program comprises of vestibular rehabilitation, at group sessions, twice a week for 9 weeks. The program is described in detail in table 1. Vestibular rehabilitation aims to facilitate rearrangement and recruitment of the control capacities of the vestibular system, by letting the patient be exposed to unstable body positions, such as standing on foam and performing head, trunk or eye-movements.
Study NCT02248636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitor
Description: This group receives a half-dose of their previous cholinesterase inhibitor medication (in overencapsulated form) for two weeks, then receives placebo.
Study NCT02248636 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sham discontinuation
Description: This group receives their previous dose of cholinesterase inhibitor medication, but in overencapsulated form
Study NCT03295617 — intervention group
Intervention type: PROCEDURE
Intervention: Thoracoscopy
Description: Thoracoscopy surgery
Study NCT02547558 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arterial blood gases
Description: Measured through radial arterial catheter
Study NCT02547558 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cardiac Output
Description: Measured through bioimpedance: FloTrac pressure transducer (FloTrac sensor; Edwards Lifesciences) using the third-generation (3.01) FloTrac software for continuous CO display.
Study NCT02547558 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vital signs
Description: As measured in clinical practice
Study NCT02547558 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exhaled breath
Description: Were recorded using a pneumotachograph (CPX/D; Med Graphics, St. Paul, MN, U.S.A.).
Study NCT02547558 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spirometry
Description: In a daily calibrated spirometer.
Study NCT00006214 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: flutamide
Study NCT00006214 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: placebo
Study NCT02758392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-61178104 Intravenous
Description: Participants will receive JNJ-61178104 Intravenously on Day 1.
Study NCT02547558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol
Description: Indacaterol Breezhaler@ 300 mcg (1 inhalation)
Study NCT02491606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tafenoquine
Description: Tafenoquine 200mg and 400 mg
Study NCT02491606 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study NCT03296943 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Essential oil
Description: To inhale the essential oil in an air-conditioned room, the container was flipped over to soak the roll-on cap that was then rolled-on circularly at the right mid-palm of the subject at 2 centimeter in diameter for 5 cycles.
Study NCT03296943 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: Perfume
Description: To inhale the perfume in an air-conditioned room, the container was flipped over to soak the roll-on cap that was then rolled-on circularly at the right mid-palm of the subject at 2 centimeter in diameter for 5 cycles.
Study NCT03296943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cue-induced inhalants craving
Description: Exposing individuals with a set of 12 pictures for one-minute (e.g., 5 second display per picture) every five minutes for three sets in total followed by another three sets of neutral/relaxing pictures of nature.
Study NCT03296943 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Cue-induced inhalants craving
Description: Exposing individuals with a set of 12 pictures for one-minute (e.g., 5 second display per picture) every five minutes for three sets in total followed by another three sets of neutral/relaxing pictures of nature.
Study NCT04718493 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Self-expandable metal stent
Description: Endoscopic stenting of intestinal stricture related to Crohn´s disease
Study NCT04718493 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Balloon dilatation
Description: Endoscopic balloon dilatation of intestinal stricture related to Crohn´s disease
Study NCT00870545 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone support groups
Description: There was one intervention. Participants were enrolled in one of 14 telephone groups (each with a trained Group Leader and 6 participants) will focus on education, training in and practice of coping skills and cognitive restructuring (identifying and re-shaping negative and destructive thoughts), and support through 12 hour-long structured sessions. The content, modeled on Soldier BATTLEMIND, targets readjustment concepts based on the letters of BATTLEMIND, including Bonds, Adding and subtracting family roles, Taking control, Talking it out, Loyalty and commitment, Emotional balance, Mental health and readiness, Independence and interdependence, Navigating the system, Denial of self and a concluding session entitled Moving forward.
Study NCT00524472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic-normoglycemic clamp
Description: Patients will be randomized to receive the hyperinsulinemic-normoglycemic clamp titrating the blood glucose to 80-110 mg/dL.
Study NCT00524472 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: insulin at the standard of care levels
Description: Subjects will be administered insulin at the standard of care levels established by the participating institution.
Study NCT02178696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo, identified as placebo to participants
Description: White tablets
Study NCT02178696 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celexa or other antidepressant as clinically indicated
Description: Open label s-citalopram, 20 mg start up dose, increasing to 40 mg as clinically indicated; If prior non-response to this medication is noted by the patient, alternative treatments may include another first-line antidepressant:fluoxetine 20 mg; paroxetine up to 60 mg; sertraline up to 200 mg; bupropion up to 300 mg
Study NCT02178696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo, identifed to participants as Active medication
Description: Blue Capsule
Study NCT04522479 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Change the injection time of long acting GnRH-a
Description: The whole dose of long acting GnRH-a drug was changed to be injected on day 21st-23rd day of menstruation
Study NCT02353728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nilotinib
Study NCT04492085 — intervention group
Intervention type: OTHER
Intervention: Questionnaire survey
Description: A customized questionnaire will be delivered by the social software WeChat to explore the prevalence, potential reasons and solutions of workplace violence against physicians of obstetrics and gynecology in China
Study NCT02758392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-61178104 Subcutaneous
Description: Participants will receive JNJ-61178104 Subcutaneously on Day 1.
Study NCT02758392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive placebo on Day 1.
Study NCT00486824 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indomethacin
Description: One 50 mg tablet of Indomethacin plus 2 pills of placebo followed by one 25 mg tablet of oral indomethacin every 6 hrs for 48 hrs.
Study NCT00486824 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nifedipine
Description: Three 10 mg tablets of Nifedipine followed by one 20 mg tablet every 6 hrs for 48 hrs.
Study NCT04499989 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INH
Description: 3 vaginal tablet of isonicotinic acid hydrazide self inserted 12 hours before IUD insertion.
Study NCT04499989 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: 3 vaginal tablet of Placebo Comparator self inserted 12 hours before IUD insertion
Study NCT00595010 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SafeCare
Description: Treatment will be based on an updated version of the SafeCare program, which specifically addresses parenting and discipline associated with child physical abuse. Participants will receive services from Comprehensive Home-Based Services.
Study NCT02650102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Risperidone
Description: a kind of antipsychotics
Study NCT02650102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olanzapine
Description: a kind of antipsychotics
Study NCT02650102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quetiapine
Description: a kind of antipsychotics
Study NCT02650102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Description: a kind of antipsychotics
Study NCT02650102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Description: a kind of antipsychotics
Study NCT01408459 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Tomato Product
Description: Motivational Telephone Counseling weekly
Study NCT02063737 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Text-message assessments only
Description: Text message assessments only. No intervention for high level fatigue.
Study NCT02063737 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text-message interventions for high level fatigue
Description: Intervention messages to promote alertness while on duty at work including activities. Additionally at the end of the shift, participants were queried on their adoption of the suggested activities and perception of the activities' effectiveness.